Business
Kalbe Farma and LIFE AI Unveil StrokeGENME to Personalize Stroke Prevention at National Scale
SINGAPORE, Dec. 11, 2025 (GLOBE NEWSWIRE) -- In a pioneering advancement that aims to reduce the increasing problem of strokes, PT Kalbe Farma Tbk - the largest publicly listed pharmaceutical company in Southeast Asia - through its subsidiary Kalgen Innolab Clinical Laboratory (Innolab) has announced StrokeGENME, a genetics-powered platform that translates DNA insights into individualized stroke-prevention plans, delivered through Kalbe’s nationwide ecosystem. Indonesia’s leading healthcare ente
About this update from Pt Kalbe Farma Tbk
[{"type":"image","alt":"LIFE AI","displaySize":"","headline":null,"caption":"LIFE AI","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":300,"url":"https://media.zenfs.com/en/globenewswire.com/e36ce2ef2db494fe4a3520cafd14095d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/h83EPeYxZ3F36lMcMsgeyg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTQyMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/e36ce2ef2db494fe4a3520cafd14095d","width":300,"height":300}},"lazy":false},{"type":"text","content":"SINGAPORE, Dec. 11, 2025 (GLOBE NEWSWIRE) -- In a pioneering advancement that aims to reduce the increasing problem of strokes, PT Kalbe Farma Tbk - the largest publicly listed pharmaceutical company in Southeast Asia - through its subsidiary Kalgen Innolab Clinical Laboratory (Innolab) has announced StrokeGENME, a genetics-powered platform that translates DNA insights into individualized stroke-prevention plans, delivered through Kalbe’s nationwide ecosystem.","length":469,"tagName":"p"},{"type":"image","alt":"Indonesia’s leading healthcare enterprise, Kalbe Farma, partners with Life AI to launch StrokeGenme, a First-of-its-Kind Platform to Personalize Strok","displaySize":"","headline":null,"caption":"Indonesia’s leading healthcare enterprise, Kalbe Farma, partners with Life AI to launch StrokeGenme, a First-of-its-Kind Platform to Personalize Strok","className":"","disableSlideshowImg":false,"size":{"original":{"width":1500,"height":750,"url":"https://media.zenfs.com/en/globenewswire.com/0abf98a96ef06ec2412df5331fdca2a7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Y0irkYy5dPfwNj7ursJSOQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/0abf98a96ef06ec2412df5331fdca2a7","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/yDgSv9A.zGmu3fLFeBXqyw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xMjAwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/0abf98a96ef06ec2412df5331fdca2a7","width":1200,"height":600}}},{"type":"text","content":"Indonesia’s leading healthcare enterprise, Kalbe Farma, partners with Life AI to launch StrokeGenme, a First-of-its-Kind Platform to Personalize Stroke Prevention Across Indonesia.","length":180,"tagName":"p"},{"type":"text","content":"Alongside LIFE AI, Kalbe has launched StrokeGENME to provide personalized pre...